Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women

被引:1206
|
作者
Bansal, Sandeep
Buring, Julie E.
Rifai, Nader
Mora, Samia
Sacks, Frank M.
Ridker, Paul M.
机构
[1] Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA
[2] Brigham & Womens Hosp, Donald W Reynolds Ctr Cardiovasc Res, Boston, MA 02215 USA
[3] Brigham & Womens Hosp, Leducq Ctr Mol & Genet Epidemiol, Boston, MA 02215 USA
[4] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA
[5] Brigham & Womens Hosp, Div Cardiol, Boston, MA 02215 USA
[6] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA
[7] Harvard Univ, Sch Publ Hlth, Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA
来源
关键词
D O I
10.1001/jama.298.3.309
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context The association of triglycerides with incident cardiovascular disease remains controversial. Although triglyceride levels are typically obtained in the fasting state, postprandial hypertriglyceridemia may play an important role in atherosclerosis. Objective To determine the association of triglyceride levels (fasting vs nonfasting) and risk of future cardiovascular events. Design, Setting, and Participants Prospective study of 26 509 initially healthy US women (20 118 fasting and 6391 nonfasting) participating in the Women's Health Study, enrolled between November 1992 and July 1995 and undergoing follow-up for a median of 11.4 years. Triglyceride levels were measured in blood samples obtained at time of enrollment. Main Outcome Measure Hazard ratios for incident cardiovascular events (nonfatal myocardial infarction, nonfatal ischemic stroke, coronary revascularization, or cardiovascular death). Results At baseline, triglyceride levels in fasting as well as nonfasting women correlated with traditional cardiac risk factors and markers of insulin resistance. During a median follow-up of 11.4 years, 1001 participants experienced an incident cardiovascular event (including 276 nonfatal myocardial infarctions, 265 ischemic strokes, 628 coronary revascularizations, and 163 cardiovascular deaths), for an overall rate of 3.46 cardiovascular events per 1000 person-years of follow-up. After adjusting for age, blood pressure, smoking, and use of hormone therapy, both fasting and nonfasting triglyceride levels predicted cardiovascular events. Among fasting participants, further adjustment for levels of total and high-density lipoprotein cholesterol and measures of insulin resistance weakened this association (fully adjusted hazard ratio [95% confidence interval] for increasing tertiles of triglyceride levels: 1 [reference], 1.21 [0.96-1.52], and 1.09 [0.85-1.41] [P = .90 for trend]). In contrast, nonfasting triglyceride levels maintained a strong independent relationship with cardiovascular events in fully adjusted models (hazard ratio [95% confidence interval] for increasing tertiles of levels: 1 [reference], 1.44 [0.90-2.29], and 1.98 [1.21-3.25] [P = .006 for trend]). In secondary analyses stratified by time since participants' last meal, triglyceride levels measured 2 to 4 hours postprandially had the strongest association with cardiovascular events (fully adjusted hazard ratio [95% confidence interval] for highest vs lowest tertiles of levels, 4.48 [1.98-10.15] [P < .001 for trend]), and this association progressively decreased with longer periods of fasting. Conclusions In this cohort of initially healthy women, nonfasting triglyceride levels were associated with incident cardiovascular events, independent of traditional cardiac risk factors, levels of other lipids, and markers of insulin resistance; by contrast, fasting triglyceride levels showed little independent relationship.
引用
收藏
页码:309 / 316
页数:8
相关论文
共 50 条
  • [1] Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in Diabetic Patients Under Statin Therapy
    Tada, Hayato
    Nomura, Akihiro
    Takamura, Masayuki
    Kawashiri, Masa-aki
    [J]. CIRCULATION, 2019, 140
  • [2] Nonfasting triglycerides and cardiovascular risk
    Yancy, William S.
    Volek, Jeff S.
    Westman, Eric C.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (17): : 2004 - 2004
  • [3] Fasting and Nonfasting Triglycerides in Cardiovascular and Other Diseases
    Pitha, J.
    Kovar, J.
    Blahova, T.
    [J]. PHYSIOLOGICAL RESEARCH, 2015, 64 : S323 - S330
  • [4] Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events
    Mora, Samia
    Rifai, Nader
    Buring, Julie E.
    Ridker, Paul M.
    [J]. CIRCULATION, 2008, 118 (10) : 993 - 1001
  • [5] Fasting Compared with Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events
    Mora, Samia
    Rifai, Nader
    Buring, Julie E.
    Ridker, Paul M.
    [J]. CIRCULATION, 2008, 118 (18) : S568 - S568
  • [6] Nonfasting triglycerides and cardiovascular risk - Reply
    Ridker, Paul M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (17): : 2005 - 2006
  • [7] Nonfasting triglycerides and risk of cardiovascular death in men and women from the Norwegian Counties Study
    Anja S. Lindman
    M. B. Veierød
    A. Tverdal
    J. I. Pedersen
    R. Selmer
    [J]. European Journal of Epidemiology, 2010, 25 : 789 - 798
  • [8] Nonfasting triglycerides and risk of cardiovascular death in men and women from the Norwegian Counties Study
    Lindman, Anja S.
    Veierod, M. B.
    Tverdal, A.
    Pedersen, J. I.
    Selmer, R.
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2010, 25 (11) : 789 - 798
  • [9] Lipoprotein(a): Fasting and nonfasting levels, inflammation, and cardiovascular risk
    Langsted, Anne
    Kamstrup, Pia R.
    Nordestgaard, Borge G.
    [J]. ATHEROSCLEROSIS, 2014, 234 (01) : 95 - 101
  • [10] Fasting versus nonfasting triglycerides and the prediction of cardiovascular risk: Do we need to revisit the oral triglyceride tolerance test?
    Ridker, Paul M.
    [J]. CLINICAL CHEMISTRY, 2008, 54 (01) : 11 - 13